Schering-Plough

• NCT01404936

  Collaborator, Phase 2, Completed, 35 people, 28 Jul 2011

• NCT01248780

  Collaborator, Phase 3, Completed, 264 people, 25 Nov 2010

• NCT01230827

  Collaborator, Phase 3, Terminated, 173 people, 29 Oct 2010

• NCT01025765

  Collaborator, Phase 4, Status unknown, 80 people, 4 Dec 2009

• NCT00973479

  Collaborator, Phase 3, Completed, 592 people, 9 Sept 2009

• NCT00916747

  Collaborator, Phase 2, Status unknown, 85 people, 9 Jun 2009

• NCT00879034

  Collaborator, Phase 2, Completed, 5 people, 9 Apr 2009

• NCT00791271

  Collaborator, Phase 1, Terminated, 17 people, 14 Nov 2008

• NCT00773474

  Collaborator, Phase 2, Terminated, 29 people, 16 Oct 2008

• NCT00715793

  Collaborator, Phase 1/2, Completed, 39 people, 15 Jul 2008

• NCT00664469

  Collaborator, Phase 3, Terminated, 64 people, 23 Apr 2008

• NCT00653276

  Collaborator, Phase 1, Completed, 13 people, 4 Apr 2008

• A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)

  Collaborator, Phase 3, Completed, 40 people, 3 Apr 2008

• NCT00597493

  Collaborator, Phase 2, Completed, 32 people, 18 Jan 2008

• NCT00597402

  Collaborator, Phase 2, Completed, 125 people, 18 Jan 2008

• NCT00589550

  Collaborator, Phase 1, Terminated, 1 person, 9 Jan 2008

• NCT00536770

  Collaborator, Phase 2, Suspended, 132 people, 28 Sept 2007

• NCT00504140

  Collaborator, Phase 2, Completed, 30 people, 19 Jul 2007

• NCT00449410

  Collaborator, Phase 4, Completed, 35 people, 20 Mar 2007

• NCT00437957

  Collaborator, Phase 1, Terminated, 10 people, 21 Feb 2007

Sources: clinicaltrials.gov